Cargando…

Novel methods to determine complement activation in human serum induced by the complex of Dezamizumab and serum amyloid P

Lack of simple and robust methods to determine complement activation in human serum induced by antigen–antibody complexes is a major hurdle for monitoring therapeutic antibody drug quality and stability. Dezamizumab is a humanized IgG1 monoclonal antibody that binds to serum amyloid P component (SAP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jianhong, Liu, Qi, White, John R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463879/ https://www.ncbi.nlm.nih.gov/pubmed/34461096 http://dx.doi.org/10.1016/j.jbc.2021.101136

Ejemplares similares

Serum Amyloid P Aids Complement-Mediated Immunity to Streptococcus pneumoniae
por: Yuste, Jose, et al.
Publicado: (2007)

An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study
por: Richards, Duncan, et al.
Publicado: (2022)

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
por: Bodin, Karl, et al.
Publicado: (2010)

Serum amyloid P inhibits granulocyte adhesion
por: Maharjan, Anu S, et al.
Publicado: (2013)

Adaptation of Microarray Assay for Serum Amyloid a Analysis in Human Serum
por: Smoldovskaya, O. V., et al.
Publicado: (2022)

Complement Interaction with Trypanosomatid Promastigotes in Normal Human Serum
por: Domínguez, Mercedes, et al.
Publicado: (2002)

Demonstration and quantitation of activation of the first complement in human serum
por: Ziccardi, RJ, et al.
Publicado: (1978)

The Development of Serum Amyloid P as a Possible Therapeutic
por: Pilling, Darrell, et al.
Publicado: (2018)

Heterogeneity of human serum amyloid A proteins
Publicado: (1980)

Association of serum hemolytic complement levels with the major histocompatibility complex in chickens
Publicado: (1976)

A unique biofilm in human deep mycoses: fungal amyloid is bound by host serum amyloid P component
por: Garcia-Sherman, Melissa C, et al.
Publicado: (2015)

Standardization of a Complement Fixation Reaction with Chicken Serum as Complement
por: Watson, Barbara K.
Publicado: (1947)

A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease
por: Whitin, John C., et al.
Publicado: (2016)

The Paradoxical Effects of Serum Amyloid-P Component on Disseminated Candidiasis
por: Klotz, Stephen A., et al.
Publicado: (2022)

Modulation of fibrin clot formation by human serum amyloid P component (SAP) and heparin
Publicado: (1983)

Characterization of the Oligomerization and Aggregation of Human Serum Amyloid A
por: Patke, Sanket, et al.
Publicado: (2013)

Serum albumin and beta-amyloid deposition in the human brain
por: Kim, Jee Wook, et al.
Publicado: (2020)

Serum Amyloid P Component Binds Fungal Surface Amyloid and Decreases Human Macrophage Phagocytosis and Secretion of Inflammatory Cytokines
por: Behrens, Nicole E., et al.
Publicado: (2019)

Aggregation of Mouse Serum Amyloid A Protein Was Promoted by Amyloid-Enhancing Factors with the More Genetically Homologous Serum Amyloid A
por: Lin, Xuguang, et al.
Publicado: (2021)

RELATION OF A β(1)-GLYCOPROTEIN OF HUMAN SERUM TO THE COMPLEMENT SYSTEM
por: Müller-Eberhard, H. J., et al.
Publicado: (1960)

The Stability of Complement-Mediated Bactericidal Activity in Human Serum against Salmonella
por: O’Shaughnessy, Colette M., et al.
Publicado: (2012)

THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO
por: Ward, Peter A., et al.
Publicado: (1965)

SLE and Serum Complement: Causative, Concomitant or Coincidental?
por: Sandhu, Vaneet, et al.
Publicado: (2017)

SLE and Serum Complement: Causative, Concomitant or Coincidental?
por: Sandhu, Vaneet, et al.
Publicado: (2018)

Binding specificity of serum amyloid P component for the pyruvate acetal of galactose
Publicado: (1984)

Nucleosome binding by serum amyloid P component from SLE patients
por: Heegaard, NHH, et al.
Publicado: (2001)

Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis
por: Murray, Lynne A, et al.
Publicado: (2010)

Serum Amyloid P and Endocrine Markers in a Cohort of Obese Children
por: Anwer, Mehwish, et al.
Publicado: (2018)

Genetic linkage between serum levels of the third component of complement and the H-2 complex
Publicado: (1975)

Partial Identification of Amyloid-β Degrading Activity in Human Serum
por: Mikawa, Ryuta, et al.
Publicado: (2019)

A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation.
por: Ogundele, M O
Publicado: (1998)

Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus
por: Doni, Andrea, et al.
Publicado: (2021)

Serum Amyloid Alpha in Parapneumonic Effusions
por: Boultadakis, Vagelis, et al.
Publicado: (2011)

Serum amyloid A – a review
por: Sack, George H.
Publicado: (2018)

Serum Amyloid A in lung transplantation
por: Vietri, Lucia, et al.
Publicado: (2020)

Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients
por: Shirai, Kumiko, et al.
Publicado: (2022)

Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E
Publicado: (1978)

Protective effect of human serum amyloid P on CCl(4)-induced acute liver injury in mice
por: Cong, Min, et al.
Publicado: (2017)

Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component
Publicado: (1988)

Elevated anti-serum amyloid P component (SAP) antibodies in SLE patients
por: Zandman-Goddard, G, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_apf2n1l5rptdis5b1t28shd7hk